Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Environmental fate & pathways

Hydrolysis

Currently viewing:

Administrative data

Link to relevant study record(s)

Reference
Endpoint:
hydrolysis
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
other: FDA-TAD no. 3.09
Deviations:
no
GLP compliance:
not specified
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: ZK 00024524
Radiolabelling:
not specified
Transformation products:
no
Key result
pH:
4
Temp.:
50 °C
DT50:
> 1 yr
Type:
not specified
Remarks on result:
hydrolytically stable based on preliminary test
Remarks:
No hydrolytic degradation occurred within 5 days
Key result
pH:
7
Temp.:
50 °C
DT50:
> 1 yr
Type:
not specified
Remarks on result:
hydrolytically stable based on preliminary test
Remarks:
No hydrolytic degradation occurred within 5 days
Key result
pH:
9
Temp.:
50
DT50:
> 1 yr
Type:
not specified
Remarks on result:
hydrolytically stable based on preliminary test
Remarks:
No hydrolytic degradation occurred within 5 days
Validity criteria fulfilled:
yes
Conclusions:
No hydrolytic degradation occurred within 5 days at pH 4, 7 and 9 at 50±0.1 °C. According to the FDA-TAD no. 3.09, the test substance can therefore be considered hydrolytically stable at pH 5, 7 and 9 (t½> 1 year at 25 °C). 
Executive summary:

Hydrolysis of non-radiolabelled ZK 232105 with ZK 35760 (no concentration reported) was studiedaccording to FDA-TAD no. 3.09 at pH 5, 7 and 9. GLP conditions were not reported. No hydrolytic degradation occurred within 5 days at pH 4, 7 and 9 at 50±0.1 °C. According to the FDA-TAD no. 3.09, ZK 35760 can therefore be considered hydrolytically stable at pH 5, 7 and 9 (t½> 1 year at 25 °C).  This study is classified acceptable and satisfies the guideline requirement for hydrolysis study.

Description of key information

No hydrolytic degradation occurred within 5 days at pH 4, 7 and 9 at 50±0.1 °C. According to the FDA-TAD no. 3.09, the test substance can therefore be considered hydrolytically stable at pH 5, 7 and 9 (t½> 1 year at 25 °C). 

Key value for chemical safety assessment

Half-life for hydrolysis:
1 yr
at the temperature of:
50 °C

Additional information